Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
about
Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/β-catenin signaling axisp53 governs telomere regulation feedback too, via TRF2.Hypothesis: neoplasms in myotonic dystrophy.Targeting PKC: a novel role for beta-catenin in ER stress and apoptotic signalingAxin1 and Axin2 are regulated by TGF- and mediate cross-talk between TGF- and Wnt signaling pathways.Requirement of the Akt/beta-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of slug.Epithelial to mesenchymal transition in the pathogenesis of uterine malignant mixed Müllerian tumours: the role of ubiquitin proteasome system and therapeutic opportunities.Upregulation of TCF4 expression as a transcriptional target of beta-catenin/p300 complexes during trans-differentiation of endometrial carcinoma cells.Thioredoxin overexpression in HT-1080 cells induced cellular senescence and sensitization to gamma radiation.Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.Secretory Leukocyte Protease Inhibitor (SLPI) expression downregulates E-cadherin, induces β-catenin re-localisation and triggers apoptosis-related events in breast cancer cells.Transcriptional upregulation of HIF-1α by NF-κB/p65 and its associations with β-catenin/p300 complexes in endometrial carcinoma cells.High levels of β-catenin promote IFNγ-induced apoptosis in hepatocellular carcinoma cells.Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas.HDAC inhibitors potentiate the apoptotic effect of enzastaurin in lymphoma cells.Transcription factor Egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of TCF4 and p300 expression during trans-differentiation of endometrial carcinoma cells.Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.Syndecan-1, a key regulator of cell viability in endometrial cancer.Effect of indomethacin on cell cycle proteins in colon cancer cell linesAkt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma.Nuclear expression and gain-of-function β-catenin mutation in glomangiopericytoma (sinonasal-type hemangiopericytoma): insight into pathogenesis and a diagnostic marker.A functional role of LEFTY during progesterone therapy for endometrial carcinoma.Transcriptional regulation of pro-apoptotic Par-4 by NF-kappaB/p65 and its function in controlling cell kinetics during early events in endometrial tumourigenesis.Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas.Induction of p16INK4A mediated by beta-catenin in a TCF4-independent manner: implications for alterations in p16INK4A and pRb expression during trans-differentiation of endometrial carcinoma cells.Ionizing Radiation-Induced Cellular Senescence in Normal, Non-transformed Cells and the Involved DNA Damage Response: A Mini Review.
P2860
Q24312971-65D730D8-AFEB-496E-B797-9DF6443AF656Q34616697-6C5806F4-7C1A-40C2-AACF-B278C24C4D2DQ35033174-4BA7D77B-6999-4294-BA7C-0442C3A5B281Q37100742-89830405-9A4E-4CAC-8C0E-EB322AF82BA7Q37110142-F0956331-8CB4-4B94-9BBF-841DBBD976EAQ37197339-C00D4978-F2BD-45BC-8570-4FCD337415E3Q38000940-F681FC4B-7D9E-49F7-BDED-B12A609FFB37Q38328523-F3ABB1A9-F6E4-475C-B6AC-61CDF91C10D3Q38513530-6114B022-BC7C-417D-B506-D24E673B15D3Q38687471-7FD118D3-3127-4537-83E2-517E7C0F1989Q38974013-8660A14F-6519-4D8D-B696-721C7B2DE119Q39094933-5869A408-E4FB-4A31-8771-E6938CF5E8F4Q39242767-890A03BA-AE26-4EB4-9773-CC92513D9E3DQ39414697-C16832C2-30F1-4937-BF48-A00A76AD93E1Q39525805-DA75C898-F9EA-4E0B-8510-6550B5AE1415Q39938896-3EC54FA8-1FAA-48A8-AEA0-5C4F4140919AQ40112340-8F93DE89-A908-4312-BBB1-DD82DBD5EB07Q40141820-C1339252-6A7A-4CDC-91CC-8054AFEB5B97Q40443296-428A7C0A-B917-443F-8FDC-4F2AEF35982BQ42592447-1D212395-D723-4E43-89BD-64032E31FDC7Q46047714-EEEE8E02-8DF3-4B4B-8008-1AEEF0D221AFQ47263835-B3CEDA50-D767-4A71-8EEC-AE81C925B0B1Q53301550-FDD368C0-6959-4C69-B30A-9533BD504982Q53577555-5852A0E9-05E9-4E40-999E-7BBF92542F40Q53609885-36BDB277-D8D5-4AD1-B4D8-92F59FBFC13DQ55267324-8E5AE5C8-B91A-48AF-BF02-2354EF21B581
P2860
Beta-catenin simultaneously induces activation of the p53-p21WAF1 pathway and overexpression of cyclin D1 during squamous differentiation of endometrial carcinoma cells.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Beta-catenin simultaneously in ...... f endometrial carcinoma cells.
@ast
Beta-catenin simultaneously in ...... f endometrial carcinoma cells.
@en
type
label
Beta-catenin simultaneously in ...... f endometrial carcinoma cells.
@ast
Beta-catenin simultaneously in ...... f endometrial carcinoma cells.
@en
prefLabel
Beta-catenin simultaneously in ...... f endometrial carcinoma cells.
@ast
Beta-catenin simultaneously in ...... f endometrial carcinoma cells.
@en
P2093
P2860
P1476
Beta-catenin simultaneously in ...... f endometrial carcinoma cells.
@en
P2093
Isao Okayasu
Makoto Saegusa
Mieko Hamano
Miki Hashimura
Takeshi Kuwata
P2860
P304
P356
10.1016/S0002-9440(10)63732-7
P407
P577
2004-05-01T00:00:00Z